SOT nke iri isii na atọ kwụsịrị n'ụzọ zuru oke, obi ụtọ nke IPHASE-US adịghị akwụsị! Nzukọ kwa afọ nke 63 nke American Society of Toxicology e mere nke ọma site na Machị 10-14, 2024, na
Na mpaghara sara mbara nke nchọpụta biomedical na ọgwụ, IPHASE ewepụtala usoro dị elu - arụmọrụ biomicrosomes ngwa, gụnyere imeju microsomes kit, eriri microsomes kit na intestinal micros.
Mkpụrụ ndụ mmaliteT bụ akụkụ dị mkpa nke usoro ahụ ji alụso ọrịa ọgụ, na-arụ ọrụ dị oke mkpa n'ịchọpụta na ịlụso ọrịa ọgụ. Usoro nke ịgbalite cell T bụ ihe mgbagwoju anya, multi-nhazi usoro nzọụkwụ
N'oge na-adịbeghị anya, IPHASE, yana njikọ Perelman School of Medicine na University of Pennsylvania, dere otu isiokwu na akwụkwọ akụkọ Antibody Therapeutics (IF=4.56) nke akpọrọ "Development of a
Ụdị nyocha PDC in vitro ADME PDC na-eburu n'uche njirimara nke ma nnukwu ma obere ụmụ irighiri ihe. Ya mere, in vitro ADME nyocha na ya kwesịrị iburu n'uche peptides homing, njikọ
Ebe ọ bụ na ọgwụ metabolizing enzyme ọrụ ji nwayọọ nwayọọ na-ebelata site na ịgbatị oge in vitro incubation, ụdị ọdịnala in vitro metabolism nwere oke dị ka oge nnabata dị mkpụmkpụ.
Nke a bụ azụmahịa mbụ mgbe ụlọ ọrụ anyị guzobechara, ngwaahịa na ọrụ na-enye afọ ojuju, anyị nwere mmalite dị mma, anyị na-atụ anya ịkwado na-aga n'ihu n'ọdịnihu!
Ụlọ ọrụ ahụ nwere ike ịnọgide na-agbanwe agbanwe na ahịa ụlọ ọrụ a, mmelite ngwaahịa ngwa ngwa na ọnụahịa dị ọnụ ala, nke a bụ imekọ ihe ọnụ nke abụọ, ọ dị mma.